How to integrate addiction medicine in psychiatry training: results of an experiment with two educational methods. Open Review of Educational Research. 6(1). 2019.
Iatrogenic opioid use disorder, chronic pain and psychiatric comorbidity: A systematic review. Gen Hosp Psychiatry. 59:37-50.. 2019.
In body experiences: Persuasion by doing. CEUR workshop proceedings. 2340. 2019.
The Montreal Cognitive Assessment (MoCA) as a cognitive screen in addiction health care: A validation study for clinical practice. Journal of Substance Use. 24(1). 2019.
Neurobiologie van verslaving. Handboek Verslaving.. 2019.
Neurodevelopmental and behavioral consequences of perinatal exposure to the HIV drug efavirenz in a rodent model. Transl Psychiatry. 9(1):84.. 2019.
Neuropsychiatric symptoms in Tanzanian HIV-infected children receiving long-term efavirenz treatment: a multicentre, cross-sectional, observational study. Lancet HIV. 6(4):e250-e258.. 2019.
Palliative care for people with substance use disorder and multiple problems: a qualitative study on experiences of patients and proxies. BMC Palliat Care. 18(1):56.. 2019.
Prevalence of cognitive impairment in patients with substance use disorder. The Authors Drug and Alcohol Review .. 2019.
Prevalence of cognitive impairment in patients with substance use disorder. Drug Alcohol Rev. 38(4):435-442.. 2019.
A Qualitative Approach in Understanding Illness Perception and Treatment Needs in Patients with Gamma Hydroxybutyrate Use Disorder.. Eur Addict Res. 25(5):248-255.. 2019.
Social anxiety disorder and childhood trauma in the context of anxiety (behavioural inhibition), impulsivity (behavioural activation) and quality of life. South African Journal of Psychiatry. 25:1-7.. 2019.
A standardized validity assessment protocol for physiological signals from wearable technology: Methodological underpinnings and an application to the E4 biosensor. Behav Res Methods.. 2019.
Substance use disorders. Handbook of intellectual disabilities – Integrating theory, research, and practice.. 2019.
A Systematic Review of Substance Use (Disorder) in Individuals with Mild to Borderline Intellectual Disability. Eur Addict Res. :1-20.. 2019.
Toxic Leukoencephalopathy Presenting as Lethal Catatonia. J Addict Med. 13(3):241-244.. 2019.
Baclofen to Prevent Relapse in Gamma-Hydroxybutyrate (GHB)-Dependent Patients: A Multicentre, Open-Label, Non-Randomized, Controlled Trial.. CNS Drugs. 32(5):437-442.. 2018.
Changes over time in Lithuanian schoolchildren's attitudes toward addictive behaviors: Promoting and preventing factors.. PLoS One. 13(12):e0208481.. 2018.
Cognitive deficits in problematic drinkers with and without mild to borderline intellectual disability. Journal of Intellectual Disabilities. 22(1):5-17.. 2018.
Gammahydroxybutyrate in hair of non-GHB and repeated GHB users: A new and optimized method.. Forensic Science International.. 2018.
The generalizability of the structure of substance abuse and antisocial behavioral syndromes: A systematic review. Psychiatry Research. 259:412-421.. 2018.
The generalizability of the structure of substance abuse and antisocial behavioral syndromes: A systematic review.. Psychiatry Res. 259:412-421.. 2018.
Hallucinogen Persisting Perception Disorder After Ibogaine Treatment for Opioid Dependence. J Clin Psychopharmacol. 38(6):646-648.. 2018.
Herstelsteun. Toepassingen in praktijk van de verslavingszorg.Ingediend.. Handboek Steunend Relationeel Handelen.. 2018.